91 related articles for article (PubMed ID: 1439090)
21. Prolonged bronchodilating effect of formoterol versus procaterol in bronchial asthma.
Chetta A; Del Donno M; Maiocchi G; Pisi G; Moretti D; Olivieri D
Ann Allergy; 1993 Feb; 70(2):171-4. PubMed ID: 8430925
[TBL] [Abstract][Full Text] [Related]
22. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
23. The duration of action of inhaled formoterol dry powder.
Quebe-Fehling E; Brambilla R; Bromly CL; Fishwick K; Walters EH; Hendrick DJ
Br J Clin Pract; 1996 Dec; 50(8):446-9. PubMed ID: 9039716
[TBL] [Abstract][Full Text] [Related]
24. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
Langley SJ; Houghton CM; Singh SD
Respiration; 2005; 72 Suppl 1():35-7. PubMed ID: 15915011
[TBL] [Abstract][Full Text] [Related]
25. Formoterol, a new long-acting bronchodilator for inhalation.
Arvidsson P; Larsson S; Löfdahl CG; Melander B; Wåhlander L; Svedmyr N
Eur Respir J; 1989 Apr; 2(4):325-30. PubMed ID: 2737271
[TBL] [Abstract][Full Text] [Related]
26. Clinically equivalent bronchodilatation achieved with formoterol delivered via Easyhaler and Aerolizer.
Dubakiene R; Nargela R; Sakalauskas R; Vahteristo M; Silvasti M; Lähelmä S
Respiration; 2006; 73(4):441-8. PubMed ID: 16432294
[TBL] [Abstract][Full Text] [Related]
27. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
Dusser D; Vicaut E; Lefrançois G;
Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
[TBL] [Abstract][Full Text] [Related]
28. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
Pauwels RA; Löfdahl CG; Postma DS; Tattersfield AE; O'Byrne P; Barnes PJ; Ullman A
N Engl J Med; 1997 Nov; 337(20):1405-11. PubMed ID: 9358137
[TBL] [Abstract][Full Text] [Related]
29. Inhaled formoterol during one year in asthma: a comparison with salbutamol.
Arvidsson P; Larsson S; Löfdahl CG; Melander B; Svedmyr N; Wåhlander L
Eur Respir J; 1991 Nov; 4(10):1168-73. PubMed ID: 1687129
[TBL] [Abstract][Full Text] [Related]
30. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler.
Masoli M; Williams M; Weatherall M; Beasley R
Respir Med; 2006 Jan; 100(1):20-5. PubMed ID: 15936933
[TBL] [Abstract][Full Text] [Related]
31. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
Molimard M; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
Respiration; 2005; 72 Suppl 1():28-34. PubMed ID: 15915010
[TBL] [Abstract][Full Text] [Related]
32. [Formoterol as inhalation powder in the treatment of patients with reversible obstructive lung diseases. A 3-month placebo-controlled comparison of the effects of formoterol and salbutamol, followed by a 12-month period with formoterol alone].
Steffensen IE; Faurschou P
Ugeskr Laeger; 1996 Dec; 158(49):7092-6. PubMed ID: 8999618
[TBL] [Abstract][Full Text] [Related]
33. The use of inhaled formoterol in the treatment of asthma.
Berger WE
Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
[TBL] [Abstract][Full Text] [Related]
34. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
35. Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis.
Moretti M; Lopez-Vidriero MT; Pavia D; Clarke SW
Thorax; 1997 Feb; 52(2):176-80. PubMed ID: 9059481
[TBL] [Abstract][Full Text] [Related]
36. Effect of beta-adrenergic agonists on mucociliary clearance.
Bennett WD
J Allergy Clin Immunol; 2002 Dec; 110(6 Suppl):S291-7. PubMed ID: 12464938
[TBL] [Abstract][Full Text] [Related]
37. Acute safety and effects on mucociliary clearance of aerosolized uridine 5'-triphosphate +/- amiloride in normal human adults.
Olivier KN; Bennett WD; Hohneker KW; Zeman KL; Edwards LJ; Boucher RC; Knowles MR
Am J Respir Crit Care Med; 1996 Jul; 154(1):217-23. PubMed ID: 8680683
[TBL] [Abstract][Full Text] [Related]
38. Respiratory function measurements in clinical pharmacological studies including an assessment of the area under the MEFV curve as a new parameter in chronic bronchitic patients.
Struthers AD; Addis GJ
Eur J Clin Pharmacol; 1988; 34(3):277-81. PubMed ID: 3396619
[TBL] [Abstract][Full Text] [Related]
39. [A functional-morphological study of the mucociliary system at stages in the disease in patients with chronic bronchitis].
Kobylianskiĭ VI; Kokosov AN; Cherniakova DN; Punin AA; Sishkova EA
Ter Arkh; 1997; 69(3):12-6. PubMed ID: 9229818
[TBL] [Abstract][Full Text] [Related]
40. Aerosol therapy with Sch 1000. Short-term mucociliary clearance in normal and bronchitic subjects and toxicology in normal subjects.
Ruffin RE; Wolff RK; Dolovich MB; Rossman CM; Fitzgerald JD; Newhouse MT
Chest; 1978 Apr; 73(4):501-6. PubMed ID: 344012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
